Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China · Delayed Price · Currency is CNY 8.66
-0.09 (-1.03%)
Feb 11, 2026, 4:00 PM EST
SHA:688189 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -368.32 | -356.9 | -10.87 | -78.83 | -161.88 | 127.97 |
Depreciation & Amortization | 37.08 | 37.08 | 37.22 | 47.89 | 37.61 | 34.44 |
Other Amortization | 1.79 | 1.79 | 0.36 | 0.55 | 0.4 | 1.1 |
Loss (Gain) From Sale of Assets | -0.59 | -0.59 | -0.17 | - | - | -0.08 |
Asset Writedown & Restructuring Costs | 31.98 | 31.98 | - | 2.74 | 16.72 | 0.8 |
Loss (Gain) From Sale of Investments | - | - | 14.91 | 5.63 | -3.33 | -8.21 |
Provision & Write-off of Bad Debts | 283.7 | 283.7 | 87.11 | 106.17 | 108.62 | 30.56 |
Other Operating Activities | 30.88 | -25.66 | 24.13 | 21.29 | 4.21 | 20.02 |
Change in Accounts Receivable | 65.9 | 65.9 | 89.27 | -240.57 | -222.41 | -475.57 |
Change in Inventory | -29.63 | -29.63 | 3.09 | 24.57 | -12.45 | -20.24 |
Change in Accounts Payable | -11.9 | -11.9 | -26.61 | -67.52 | 207.57 | 9.98 |
Operating Cash Flow | 46.51 | 1.39 | 215.23 | -160.09 | -63.11 | -290.84 |
Operating Cash Flow Growth | -70.33% | -99.35% | - | - | - | - |
Capital Expenditures | -92.03 | -58.43 | -31.49 | -41.01 | -113.59 | -27.5 |
Sale of Property, Plant & Equipment | 6.28 | 1.88 | 0.06 | - | - | 0.08 |
Investment in Securities | 100 | 100 | -100.46 | - | 660 | -660 |
Other Investing Activities | -99.53 | 0.85 | - | 212.37 | -194.11 | 5.65 |
Investing Cash Flow | -85.27 | 44.31 | -131.89 | 171.37 | 352.3 | -681.77 |
Short-Term Debt Issued | - | 119 | 300 | - | - | - |
Long-Term Debt Issued | - | 100 | 138.8 | 490 | 465 | 235 |
Total Debt Issued | 219 | 219 | 438.8 | 490 | 465 | 235 |
Short-Term Debt Repaid | - | -323.8 | -653.78 | - | - | - |
Long-Term Debt Repaid | - | - | - | -502.11 | -261.46 | -230.39 |
Total Debt Repaid | -135 | -323.8 | -653.78 | -502.11 | -261.46 | -230.39 |
Net Debt Issued (Repaid) | 84 | -104.8 | -214.98 | -12.11 | 203.54 | 4.61 |
Issuance of Common Stock | - | - | - | - | - | 1,148 |
Repurchase of Common Stock | -10 | -10 | - | - | - | - |
Common Dividends Paid | -4.27 | -5.23 | -15.82 | -16.36 | -56.31 | -13.51 |
Other Financing Activities | 3.19 | 2.86 | -4.28 | - | -5.1 | -21.29 |
Financing Cash Flow | 72.92 | -117.16 | -235.08 | -28.47 | 142.13 | 1,117 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.02 |
Net Cash Flow | 34.16 | -71.46 | -151.74 | -17.2 | 431.32 | 144.76 |
Free Cash Flow | -45.52 | -57.03 | 183.74 | -201.1 | -176.7 | -318.34 |
Free Cash Flow Margin | -47.75% | -21.66% | 25.52% | -28.78% | -23.76% | -30.93% |
Free Cash Flow Per Share | -0.17 | -0.21 | 0.67 | -0.73 | -0.64 | -1.24 |
Cash Income Tax Paid | 7.58 | 40.69 | 89.02 | 76.84 | 94.19 | 118.24 |
Levered Free Cash Flow | 84.42 | 86.72 | 172.15 | -102.39 | -204.91 | -379.51 |
Unlevered Free Cash Flow | 86.98 | 90.1 | 181.68 | -88.61 | -194.95 | -371.15 |
Change in Working Capital | 30 | 30 | 62.55 | -265.52 | -65.46 | -497.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.